BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tawfik D, Zaccagnino A, Bernt A, Szczepanowski M, Klapper W, Schwab A, Kalthoff H, Trauzold A. The A818-6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer. BMC Cancer 2020;20:264. [PMID: 32228510 DOI: 10.1186/s12885-020-06773-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kalthoff H. How open is the therapeutic horizon for pancreatic cancer patients? Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00204-6. [PMID: 34789410 DOI: 10.1016/j.hbpd.2021.11.005] [Reference Citation Analysis]
2 Schnipper J, Dhennin-Duthille I, Ahidouch A, Ouadid-Ahidouch H. Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma. Front Pharmacol 2020;11:568993. [PMID: 33178018 DOI: 10.3389/fphar.2020.568993] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Miao X, Zou H, Pan L, Cheng J, Wu Y, Chen R, Su Y, Du H, Ding X. Circ_0110940 Exerts an Antiapoptotic and Pro-Proliferative Effect in Gastric Cancer Cells via the miR-1178-3p/SLC38A6 Axis. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/3494057] [Reference Citation Analysis]
4 Khattar V, Wang L, Peng JB. Calcium selective channel TRPV6: Structure, function, and implications in health and disease. Gene 2022;817:146192. [PMID: 35031425 DOI: 10.1016/j.gene.2022.146192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gandasi NR, Arapi V, Mickael ME, Belekar PA, Granlund L, Kothegala L, Fredriksson R, Bagchi S. Glutamine Uptake via SNAT6 and Caveolin Regulates Glutamine-Glutamate Cycle. Int J Mol Sci 2021;22:1167. [PMID: 33503881 DOI: 10.3390/ijms22031167] [Reference Citation Analysis]
6 Hofschröer V, Najder K, Rugi M, Bouazzi R, Cozzolino M, Arcangeli A, Panyi G, Schwab A. Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy. Front Pharmacol 2020;11:586599. [PMID: 33841132 DOI: 10.3389/fphar.2020.586599] [Cited by in F6Publishing: 1] [Reference Citation Analysis]